Douglas Flora: AI in Precision Oncology Journal Reaches New Milestone
Douglas Flora/ medium.com

Douglas Flora: AI in Precision Oncology Journal Reaches New Milestone

Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, shared a post by AI in Precision Oncology, on LinkedIn, adding:

“Original manuscripts at AI in Precision Oncology have doubled over the last year. And we just earned our provisional Web of Science listing. When Nikhil Thaker, and I started this thing, a peer-reviewed journal on AI in cancer care sounded either premature or a little crazy, and some days it was both. Watching it grow into something real, with serious science arriving from serious people, has been pretty special.

Credit belongs to our contributors, to Sage, and to an editorial board that shows up and does the unglamorous work of review. This month, we add three new names to that esteemed list: Welcome to the AIPO team Robert Uzzo, Matthew Kurian, and Jasmin Hundal.

If you’re working in this space, we’d love to publish your work. Original research, reviews welcome, as are thoughtful commentaries or other front matter our readership should see. Reach out here if you have an idea you’d like to write about. I just accepted a great one, authored by Zara Baloch, on the risk not just of ‘deskilling’ in medical training through AI shortcuts, but of ‘never-skilling’ altogether. Keep thoughtful pieces like this coming.

And Nikhil, my friend: building this with you remains a distinct privilege and honor. Now back to the inbox of submissions we asked for.”

Quoting AI in Precision Oncology’s post:

“Stay up to date with the latest research in AI in Precision Oncology.

Explore recent articles examining how artificial intelligence is advancing cancer research, supporting clinical decision-making, and helping to drive more personalized approaches to care.”

Read more.

Other articles about Precision Oncology on OncoDaily.